Pegylated liposomal doxorubicin (Caelyx): contemporary aspects of its application in hematology

Pegylated liposomal doxorubicin (Caelyx): contemporary aspects of its application in hematology

.

Saved in:

Bibliographic Details
Main Authors:	O. A. Rukavitsin, V. P. Pop
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/698
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
by: Alberto A Gabizon, et al.
Published: (2025-01-01)

Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01)

The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma
by: Trang Pham, et al.
Published: (2025-04-01)

Diffuse Erythematous Follicular Eruption Induced by Pegylated Liposomal Doxorubicin
by: Zhong L, et al.
Published: (2025-04-01)

Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma
by: Marco Mazzotta, et al.
Published: (2016-01-01)

Pegylated liposomal doxorubicin does not affect cardiac function in patients treated for gynecologic malignancies
by: Khrystyna Levytska, et al.
Published: (2025-04-01)

Characterization and in vitro anticancer study of PEGylated liposome dually loaded with ferulic acid and doxorubicin
by: Andang Miatmoko, et al.
Published: (2025-01-01)

Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma
by: Ye T, et al.
Published: (2025-08-01)

Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy
by: Tarek S. Karam, et al.
Published: (2025-05-01)

Enhancing targeted delivery and efficacy of PEGylated liposomal doxorubicin with liposomal minoxidil: comprehensive in silico, in vitro, and in vivo tumor model studies
by: Vahideh Mohammadzadeh, et al.
Published: (2025-12-01)

Long-term effect of pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer: а clinical case
by: I. A. Pokataev, et al.
Published: (2015-11-01)

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis
by: Christopher W. Hoeger, et al.
Published: (2025-07-01)

Remote Co-Loading of Doxorubicin and Hydralazine into PEGylated Liposomes: In Vitro Anti-Proliferative Effect Against Breast Cancer
by: Walhan Alshaer, et al.
Published: (2025-03-01)

Doxorubicin-loaded PEGylated liposome modified with ANGPT2-specific peptide for integrative glioma-targeted imaging and therapy
by: Hongyan Li, et al.
Published: (2025-02-01)

Analysis of phytosterols encapsulated in pegylated liposomes
by: Joanna Igielska-Kalwat, et al.
Published: (2025-08-01)

The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan
by: Chih-Chiang Hung, et al.
Published: (2020-01-01)

The Efficacy and Safety of Pegylated Liposomal Doxorubicin‐Based Neoadjuvant Chemotherapy in Children With Osteosarcoma: A Retrospective Real‐World Study
by: Guoqi Wang, et al.
Published: (2025-04-01)

Analysis of risk factors in breast cancer patients with hand-foot syndrome and oral mucositis caused by pegylated liposomal doxorubicin
by: Xianghua Quan, et al.
Published: (2025-05-01)

Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.
by: Alexander V Andriyanov, et al.
Published: (2014-01-01)

In Vitro Study of Antitumor and Antimicrobial Activity of a Preparation of Pegylated Liposomes with Sanguinarine
by: S. V. Lutsenko, et al.
Published: (2020-05-01)

The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells
by: Annalisa Carretta, et al.
Published: (2024-09-01)

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01)

Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug
by: Wu X, et al.
Published: (2024-11-01)

Secondary ions mass spectrometric method for assessing surface density of pegylated liposomal nanomedicines
by: Francesco Fumagalli, et al.
Published: (2025-07-01)

Matrix Metalloproteinase-2-Responsive Peptide-Modified Cleavable PEGylated Liposomes for Paclitaxel Delivery
by: Xingyu Zhao, et al.
Published: (2025-07-01)

Substituting Doxorubicin with Nonpegylated Liposomal Doxorubicin for the Treatment of Early Breast Cancer: Results of a Retrospective Study
by: Neville Davidson, et al.
Published: (2014-01-01)

Mitigation of radiation-induced esophageal fibrosis by macrophage-targeted phosphatidylserine-containing liposomes with partial PEGylation
by: Gyeung Mi Seon, et al.
Published: (2025-10-01)

PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer
by: Ammar Said Suliman, et al.
Published: (2025-03-01)

The effectiveness of liposomal doxorubicin hydrochloride in combination with cyclophosphan in the treatment of breast cancer in an experiment
by: L. A. Balykova, et al.
Published: (2021-12-01)

Adenoviruses Encapsulated in PEGylated DOTAP-Folate Liposomes Are Protected from the Pre-Existing Humoral Immune Response
by: Abraham T. Phung, et al.
Published: (2025-06-01)

Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study
by: Bingqing Luo PhD, et al.
Published: (2025-03-01)

Preparation and Characterization of Hydrophobin 4-Coated Liposomes for Doxorubicin Delivery to Cancer Cells
by: Fatma Hande Osmanagaoglu, et al.
Published: (2024-10-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Distinct In Vitro Effects of Liposomal and Nanostructured Lipid Nanoformulations with Entrapped Acidic and Neutral Doxorubicin on B16-F10 Melanoma and Walker 256 Carcinoma Cells
by: Roxana Pop, et al.
Published: (2025-07-01)

Reversible Electroporation–Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With Zr-Labeled Reporter Nanoparticles
by: Govindarajan Srimathveeravalli PhD, et al.
Published: (2018-02-01)

Effects of orally administration free and Liposomal Levamisole on hematological and biochemical parameters in Sheep
by: Hasan Susar, et al.
Published: (2025-04-01)

Study of the immunotoxic properties of pegylated hyaluronidase
by: K. I. Ershov, et al.
Published: (2023-10-01)

Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy.
by: Zhao Peng, et al.
Published: (2014-01-01)

Complete remission in a rare pelvic angiosarcoma with liposomal doxorubicin: A comprehensive case report and review of literature
by: Truls Gråberg, et al.
Published: (2025-02-01)

Research on Doxorubicin-Induced Cardiotoxicity Mechanism and Its Forensic Application
by: ZHANG Shuai, et al.
Published: (2025-04-01)